Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline - PubMed (original) (raw)

Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline

Nilka Ríos Burrows et al. Diabetes Care. 2010 Jan.

Abstract

Objective: We examined trends in incidence of treatment for diabetes-related end-stage renal disease (ESRD) in the U.S.

Research design and methods: Using the U.S. Renal Data System, we obtained the number of individuals having diabetes listed as primary diagnosis who initiated ESRD treatment between 1990 and 2006. Incidence was calculated using the estimated U.S. population with diabetes from the National Health Interview Survey and then was age adjusted based on the 2000 U.S. standard population. Trends were analyzed using joinpoint regression.

Results: The number of individuals who began diabetes-related ESRD treatment increased from 17,727 in 1990 to 48,215 in 2006. From 1990 to 1996, the age-adjusted diabetes-related ESRD incidence increased somewhat from 299.0 to 343.2 per 100,000 diabetic population (P = 0.45). However, from 1996 to 2006, the age-adjusted diabetes-related ESRD incidence decreased by 3.9% per year (P < 0.01) from 343.2 to 197.7 per 100,000 diabetic population. Among individuals with diabetes aged <45 years, diabetes-related ESRD incidence decreased by 4.3% per year (P < 0.01) from 1990 to 2006. Among older individuals, incidence increased during the 1990s but decreased in later years, by 3.9% per year (P < 0.01) among individuals aged 45-64, by 3.4% per year (P < 0.01) among individuals aged 65-74 years, and by 2.1% per year (P = 0.02) among individuals aged > or =75 years.

Conclusions: Diabetes-related ESRD incidence in the diabetic population has declined in all age-groups, probably because of a reduction in the prevalence of ESRD risk factors, improved treatment and care, and other factors.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Modeled age-specific incidence of diabetes-related ESRD in the population with diabetes, U.S., 1990–2006. Predicted values: ▲——▲, <45 years; ■——■, 45–64 years; ●——●, 65–74 years; ——, ≥75 years. Predicted values were modeled using joinpoint regression analysis.

Figure 2

Figure 2

Modeled age-adjusted incidence of diabetes-related ESRD in the population with diabetes, by sex and race or ethnicity, U.S., 1990–2006. Predicted values: – – –, women; ●——●, men; ▲——▲, whites; ■——■, blacks; ——, Hispanics. Predicted values were modeled using joinpoint regression analysis. The racial groups include individuals of both Hispanic and non-Hispanic origin; Hispanics may be of any race. NHIS began collecting Hispanic ethnicity data in 1997.

Comment in

Similar articles

Cited by

References

    1. United States Renal Data System. USRDS 2008 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2008
    1. Centers for Disease Control and Prevention. Diabetes data & trends [article online]. Available from http://www.cdc.gov/diabetes/statistics/index.htm Accessed 28 January 2009
    1. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2007. Atlanta, GA, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2008
    1. Burrows NR, Wang J, Geiss LS, Venkat Narayan KM, Engelgau MM: Incidence of end-stage renal disease among persons with diabetes—United States, 1990–2002. MMWR Morb Mortal Wkly Rep 2005; 54: 1097– 1100 - PubMed
    1. United States Renal Data System. Researcher's Guide to the USRDS Database. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2007

MeSH terms

LinkOut - more resources